Myocardial involvement in end-stage renal disease patients with anemia as assessed by cardiovascular magnetic resonance native T1 mapping: An observational study

Lin Chen,Rong Xu,Huayan Xu,Zhigang Yang,Yi Zhang,Zhenlin Li,Chunchao Xia,Li Rao,Yingkun Guo
DOI: https://doi.org/10.1097/md.0000000000039724
IF: 1.6
2024-11-28
Medicine
Abstract:Cardiovascular disease has become to the main cause of death in the end-stage renal disease (ESRD) patients. Cardiovascular morbidity and mortality in ESRD patients is about 10 to 20 times higher than in the general population. [ 1–4 ] Although increased cardiac mortality has been considered as a consequence of nonatherosclerotic processes, sudden cardiac death is a significant characteristic in ESRD patients. [ 5 , 6 ] Myocardial fibrosis is likely to contribute to the ultimate development of cardiac death.
medicine, general & internal
What problem does this paper attempt to address?